In addition, to determine the therapeutic effect of fraxinellone on liver fibrosis, we administered fraxinellone in mice five weeks or three weeks after the CCL4 treatment and found that fraxinellone was able to inhibit the progression of established fibrosis (Supplementary Fig. 7). The gene discussed is CCL4; the disease is Hepatic fibrosis.